Thermo Fisher Scientific Introduces the QuantStudio 5 Real-Time PCR System for the Modern Forensic Laboratory

Validated for human identification, the system drives efficiencies and positions casework laboratories for future advancements

Wednesday, March 15, 2017 8:00 am EDT

Dateline:

CARLSBAD, Calif.
"As technology continues to evolve, its remains critically important for laboratories to be well-positioned for the inevitable advancements in the future"

CARLSBAD, Calif.--(BUSINESS WIRE)--Forensic scientists who want to modernize their laboratories now have access to the Applied Biosystems QuantStudio 5 Real-Time PCR System for Human Identification. Paired with the complementary analysis software and Thermo Fisher Scientific’s leading DNA chemistries, the complete solution is designed to meet evolving needs and help labs stay ahead of future technological advancements.

Today’s forensic space is undergoing a technological revolution that is driving lab instruments to become increasingly efficient, economical, interactive and future-proof. Technicians that perform their sample quantification step on older, larger and more complex qPCR systems can face costly and more frequent instrument maintenance, while also spending valuable time manually running standard curves during the quantification process.

The QuantStudio 5 Real-Time PCR System for Human Identification is designed to deliver efficient performance with a smaller footprint and lower annual maintenance costs. It has been optimized for use with the new HID Real-Time PCR Analysis Software v1.3, which enables data analysis with a virtual standard curve feature to minimize variation and reduce costs associated with using standards on every plate. The software also includes quantification and short tandem repeat (STR) setup features, as well as data quality–review functionality that integrate and streamline quantification and STR analysis.

When combined with the Applied Biosystems Quantifiler HP and Quantifiler Trio DNA Quantification kits, the entire solution offers a validated workflow that enables forensic labs to simultaneously obtain a quantitative and qualitative assessment of human DNA in their casework samples to better determine downstream processing and successfully extract an STR profile.

“As technology continues to evolve, its remains critically important for laboratories to be well-positioned for the inevitable advancements in the future,” said Rosy Lee, vice president and general manager of human identification at Thermo Fisher Scientific. “Our new validated and comprehensive solution for upstream casework analysis is designed to help our customers stay on the leading edge with the most advanced qPCR technology, while enabling cost savings and efficiencies that help meet their needs.”

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $18 billion and more than 55,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.

Contact:

Thermo Fisher Scientific
Mauricio Minotta, 760-929-2456
Mauricio.minotta@thermofisher.com

Thermo Fisher Tweets

Introducing the first NGS-based IVD test for detection of genetic mutations in #NSCLC - Oncomine Dx Target Test… https://t.co/jR0BLLcoT0-3 hours 55 min ago
Hi, Can you plz share serial # of your Vanquish system & your location? We can connect you with the right team. Thanks.-7 hours 45 min ago
Scientists will do just about anything to get an automated cell counter! https://t.co/iWeiF2rvuX See the rebellion. https://t.co/8d3TauNecG-8 hours 17 min ago
What’s the advantage of exceptionally bright readouts for better discrimination of cell subpopulations?… https://t.co/0LbS3hM38m-8 hours 17 min ago
We've just received FDA approval for the first NGS-based IVD test for detection of genetic mutations in #NSCLC https://t.co/uXlmLlmTq1-1 day 2 hours ago